FDA Inspection
Pfizer Ireland Pharmaceuticals Unlimited CompanyPfizer Ireland Pharmaceuticals Unlimited Company – FDA Inspection, Mar 10, 2017
Record Details
This FDA Inspection record concerns Pfizer Ireland Pharmaceuticals Unlimited Company, with an inspection on March 10, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- March 10, 2017
- Product Type
- Drugs
View Company Profile
ID · cd31d16b-3fdd-4d55-a4a0-f7a897c4a251
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1007326
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.160(a)Deviations from laboratory control requirements
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Pfizer Ireland Pharmaceuticals Unlimited Company
12| Date | Classification | Office | Project area |
|---|---|---|---|
| December 15, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 11, 2023 | Not classified | Office of Inspections and Investigations | |
| January 24, 2023 | Not classified | Office of Inspections and Investigations | |
| November 12, 2019 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| November 9, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Pfizer Ireland Pharmaceuticals Unlimited Company
- FDA Inspection 1270977 - 2023-12-15
- FDA Inspection 1208210 - 2023-05-11
- FDA Inspection 1201722 - 2023-01-24
- FDA Inspection 1109599 - 2019-11-12
- FDA Inspection 1112255 - 2018-11-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.